speb/financial-data huggingface dataset:
Financial scorecard for 2350.HK (Technology — Information Technology Services, Hong Kong)
Report date: 2025-09-30 (quarterly)
Stock price: 0.0778061224489796
Market cap: 475037536 (USD: 61058809.25449871)
P/B ratio: 2.7629291483851133
Debt to equity: 0.028300000000000002
Current ratio: 1.58
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 9.551455740120714
Total shareholder yield (%): 9.551455740120714 (Moderate Return)
Momentum (%): 1m -18.66666666666666, 3m -22.883298889175922, 6m -37.434252051335996, 12m 38.813195732838594, composite 3.4514703420309636 (Strong Uptrend)
Lynch category:  (confidence: Low)
Screener: long score 2, short score 3, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.6229238322829094 (Likely Safe)
Equity multiplier (leverage): 2.5929958573992637
ROE archetype: Standard Business
FCF z-score: 2.4314783825232444
Treasury beta 1y: -0.10709598854097227 (R-squared: 0.0016779843002524921)
Insider 90-day net shares: -132500000 (net value USD: -9881500.00)
ROIC (%): -0.8853003932356418 (pretax: -1.1206334091590402)
Incremental ROIC 3y (%): -54.73725029681328 (pretax: -66.95124958181421)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 52.4416135881104, ROIC 68.78980891719745, revenue growth 1y , 6m momentum 78.343949044586
Sector percentiles: P/E , 6m momentum 70.97097097097097
Industry median P/E: 0.21619799348899724; industry median ROIC: 12.533738935242045
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.05621190212500229
Base cash flow: -756426.735218509
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 2577.HK (Technology — Semiconductors, China)
Report date: 2025-12-31 (annual)
Stock price: 5.612244897959184
Market cap: 40264429568 (USD: 5752061366.857142)
P/B ratio: 8.793138320456414
Debt to equity: 0.5467
Current ratio: 5.29
Interest coverage ratio: -9.132480689449679
Return on net tangible assets (%): -13.051512491810172
Buffett classification: The Gruesome
Analyst consensus upside (%): 859.7320561941252
Rule of 40 score: -44.631540339124065
Altman Z-score: 6.684628680232367 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.9678032013294974
Total shareholder yield (%): -0.9678032013294974 (Minimal or Negative)
Momentum (%): 1m -36.462093862815884, 3m -31.55159259965668, 6m -30.84437566495792, 12m -3.385696383816689, composite -3.4460763501693017 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 1, short score 3, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: 0.02849686745148648
FCF conversion rate: 1.2100324444714121
Beneish M-score: -3.9920327281022345 (Likely Safe)
Equity multiplier (leverage): 1.8741900945077345
ROE archetype: Standard Business
Treasury beta 1y: -0.12612367428783527 (R-squared: 0.0021222144386595348)
Insider 90-day net shares: -3389134 (net value USD: -29613616.00)
ROIC (%): -16.302785243876194 (pretax: -20.636437017564806)
Incremental ROIC 3y (%): 252.90570308370656 (pretax: 320.1338013717804)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 62.96296296296296, ROIC 71.60493827160494, revenue growth 1y , 6m momentum 79.01234567901234
Sector percentiles: P/E , 6m momentum 65.7323990657324
Industry median P/E: 31.956834532374103; industry median ROIC: 3.679818125534067
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.10131703404125557
Base cash flow: -75412571.42857143
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 2586.HK (Technology — Software - Infrastructure, China)
Report date: 2025-12-31 (annual)
Stock price: 0.6798469387755103
Market cap: 4616162816 (USD: 659451830.8571428)
P/E ratio: 5.36821412369575
P/B ratio: 5.789849560529712
Debt to equity: 0.38549999999999995
Current ratio: 1.89
Interest coverage ratio: 9.588361760068798
Return on net tangible assets (%): 28.424267964918894
Buffett classification: The Great
Analyst consensus upside (%): 1106.4478873239436
Rule of 40 score: 30.065596971605277
Piotroski F-score: 8 (Strong)
Magic formula: return on capital % 18.322647085406903, earnings yield % 0.4324596928172903, rank 3144
Dividend yield (%): 0
Buyback yield (%): 4.266097359422082
Debt paydown yield (%): 3.5932607608285814
Total shareholder yield (%): 7.859358120250663 (Moderate Return)
Momentum (%): 1m -17.873651771956855, 3m -25.235933558816782, 6m -37.540563928751716, 12m -53.02114023426271, composite -35.191115180056606 (Strong Downtrend)
Lynch category:  (confidence: Low)
Screener: long score 10, short score 4, recommendation: Neutral
Revenue growth 1y (%): 24.915863457919897
Revenue CAGR 3y (%): 18.567722063091875
Revenue deceleration: no
Revenue growth consistency score: 13.149694952090174
Beneish M-score: -2.534618171086951 (Likely Safe)
ROE (%): 17.032112684155965
Net margin (%): 6.005327929957301
Asset turnover: 1.3393097537239753
Equity multiplier (leverage): 2.117633322924662
ROE archetype: Balanced Compounder
P/E z-score: 1.3174632022540604
FCF z-score: 1.3174632022540613
Treasury beta 1y: -0.021335515599424214 (R-squared: 0.0001703407801346232)
Insider 90-day net shares: -435800 (net value USD: -523190.00)
ROIC (%): 27.689859689199515 (pretax: 35.050455302784194)
Incremental ROIC 3y (%): 154.88348065952476 (pretax: 196.055038809525)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 26.923076923076923, P/B 54.52488687782805, ROIC 13.800904977375566, revenue growth 1y 21.71945701357466, 6m momentum 71.04072398190046
Sector percentiles: P/E 31.73173173173173, 6m momentum 71.00433767100434
Industry median P/E: 5.36821412369575; industry median ROIC: 3.7232145830700096
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.1010888686446519
Base cash flow: 27557571.428571425
DCF price per share: base 0.19928213937170067, conservative 0.1217450237245165, aggressive 0.33629163094969683
Financial scorecard for 2616.HK (Healthcare — Biotechnology, China)
Report date: 2025-12-31 (annual)
Stock price: 0.5892857142857143
Market cap: 7364798976 (USD: 1052114139.4285715)
P/B ratio: 12.371616777883045
Debt to equity: 0.5650999999999999
Current ratio: 2.18
Interest coverage ratio: -31.456826401446655
Return on net tangible assets (%): -84.14411174055091
Buffett classification: The Gruesome
Analyst consensus upside (%): 1995.6278195488726
Rule of 40 score: -161.42687917368914
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.4559063253291226
Total shareholder yield (%): 0.4559063253291226 (Low Return)
Momentum (%): 1m -1.4925373134328488, 3m -52.33360389610389, 6m -18.647281921618212, 12m -38.97238974745571, composite -36.34287160125854 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Beneish M-score: -2.481284565277135 (Likely Safe)
Equity multiplier (leverage): 2.7284375258094378
ROE archetype: Standard Business
Treasury beta 1y: -0.03813895816262408 (R-squared: 0.00022412326274049197)
Insider 90-day net shares: 2137500 (net value USD: 1237991.00)
ROIC (%): -707.9679953635132 (pretax: -896.162019447485)
Incremental ROIC 3y (%): 109.27292337454698 (pretax: 138.3201561703126)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 59.205776173285194, ROIC 39.62093862815885, revenue growth 1y , 6m momentum 42.32851985559567
Sector percentiles: P/E , 6m momentum 48.96131805157593
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.06044475446981864
Base cash flow: -56146000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 3683.HK (Industrials — Marine Shipping, Hong Kong)
Report date: 2025-09-30 (quarterly)
Stock price: 0.005102040816326531
Market cap: 37151928 (USD: 4775312.082262211)
P/B ratio: 8.959449922407709
Debt to equity: 7.7309
Current ratio: 0.03
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -3.509912056246447
Total shareholder yield (%): -3.509912056246447 (Minimal or Negative)
Momentum (%): 1m -33.33333333333333, 3m -33.418367346938766, 6m -50.255102040816325, 12m -66.62414965986395, composite -44.53656462585034 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 0, short score 4, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.4791790825738227 (Likely Safe)
Equity multiplier (leverage): 9.569994307302176
ROE archetype: Standard Business
Treasury beta 1y: 0.3944816827047282 (R-squared: 0.019270664040065062)
Insider 90-day net shares: -602500 (net value USD: -5806.00)
ROIC (%): -3.983418725176074 (pretax: -5.042302183767182)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 74.46808510638297, ROIC 76.59574468085107, revenue growth 1y , 6m momentum 84.39716312056737
Sector percentiles: P/E , 6m momentum 83.12852022529442
Industry median P/E: 1.0985700514138816; industry median ROIC: 4.741763128508353
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.09397236978030557
Base cash flow: -1383033.4190231361
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 6160.HK (Healthcare — Biotechnology, Switzerland)
Report date: 2026-03-31 (quarterly)
Stock price: 25.408163265306122
Market cap: 268674154496 (USD: 335842693120)
P/E ratio: 8.197661086906674
P/B ratio: 4.537923940315986
Debt to equity: 0.4313
Current ratio: 3.64
Interest coverage ratio: 7.598808039650926
Return on net tangible assets (%): 4.846213714636688
Buffett classification: The Great
Analyst consensus upside (%): 1072.3449883449885
Rule of 40 score: -2.6706116497927423
Altman Z-score: 42.16375115474464 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Magic formula: return on capital % 3.798783730086947, earnings yield % 0.10954545451219706, rank 2203
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.015718494294619006
Total shareholder yield (%): -0.015718494294619006 (Minimal or Negative)
Momentum (%): 1m 20.581113801452794, 3m 9.793553182862548, 6m -2.9462911511323426, 12m 11.426861247292205, composite -0.24817256564034848 (Moderate Downtrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 7, short score 2, recommendation: Neutral
Revenue growth 1y (%): 48.76712240708652
Net income growth 1y (%): 19592.338582677166
Revenue deceleration: no
Accrual ratio: 0.007931926324007958
FCF conversion rate: 0.706144961448295
Beneish M-score: -2.5254595170999714 (Likely Safe)
ROE (%): 4.955016662348376
Net margin (%): 12.007305033195333
Asset turnover: 0.22480190455499932
Equity multiplier (leverage): 1.8356910451016208
ROE archetype: Low Return
P/E z-score: 1.9143334328930883
FCF z-score: 1.9143334328930888
Treasury beta 1y: -0.08003071886971638 (R-squared: 0.004165620813277516)
Insider 90-day net shares: -149357 (net value USD: -3557018.00)
ROIC (%): 33.95193432287902 (pretax: 49.3251024811695)
Incremental ROIC 3y (%): 290.3128944407457 (pretax: 378.4622501316749)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 7.671480144404332, P/B 43.592057761732846, ROIC 2.256317689530686, revenue growth 1y 8.844765342960288, 6m momentum 30.776173285198556
Sector percentiles: P/E 19.23352435530086, 6m momentum 32.77220630372493
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.07169806381490526
Base cash flow: 307316455.6962025
DCF price per share: base 18.359157125105153, conservative 11.453222405291424, aggressive 31.47388962141669
Financial scorecard for 6657.HK (Technology — Software - Application, China)
Report date: 2025-12-31 (annual)
Stock price: 2.0408163265306123
Market cap: 3614508032 (USD: 516358290.28571427)
P/B ratio: 4.364860123485109
Debt to equity: 0.0146
Current ratio: 3.94
Interest coverage ratio: -37.36363636363637
Buffett classification: The Gruesome
Rule of 40 score: -9.417153968786284
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.18477970465851015
Total shareholder yield (%): 0.18477970465851015 (Low Return)
Momentum (%): 1m 33.66750208855471, 3m 6.530612244897964, 6m -6.086328336644383, 12m -14.694312229684217, composite -11.912132809526305 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 2, short score 3, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: 0.1420518458421729
FCF conversion rate: 17.993248857498962
Beneish M-score: -0.025034649091075722 (Strong Manipulation Signal)
Equity multiplier (leverage): 1.2592579106576967
ROE archetype: Standard Business
Treasury beta 1y: 0.055955359599130707 (R-squared: 0.0005928185947376648)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -3.257267814148864 (pretax: -4.123123815378309)
Incremental ROIC 3y (%): 2.4418777117221295 (pretax: 3.0909844452178854)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 51.482479784366575, ROIC 52.156334231805936, revenue growth 1y , 6m momentum 30.727762803234505
Sector percentiles: P/E , 6m momentum 38.9723056389723
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.07547561785278865
Base cash flow: 730571.4285714286
DCF price per share: base 0.068158370452235, conservative 0.05972617877885137, aggressive 0.08261478713927528
Financial scorecard for 6938.HK (Healthcare — Biotechnology, China)
Report date: 2025-12-31 (annual)
Stock price: 6.836734693877552
Market cap: 9115424768 (USD: 1302203538.2857144)
Debt to equity: 20.5449
Current ratio: 0.86
Interest coverage ratio: -11.703530948271839
Buffett classification: The Gruesome
Rule of 40 score: -199.71995066733805
Altman Z-score: 2.7967996517099354 (Grey Zone)
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -1.522839485862924
Total shareholder yield (%): -1.522839485862924 (Minimal or Negative)
Momentum (%): 1m 9.836065573770512, 3m -14.349387755102027, 6m -32.24074890439022, 12m , composite -23.295068329746126 (Strong Downtrend)
Lynch category:  (confidence: Low)
Screener: long score 0, short score 4, recommendation: Neutral
Revenue growth 1y (%): 8.587234034028812
Revenue deceleration: yes
Revenue growth consistency score: 223167.74065477573
Beneish M-score: -2.456185588003946 (Likely Safe)
Net margin (%): -187.23250959531342
Asset turnover: 0.20289368238204072
ROE archetype: Standard Business
Treasury beta 1y: 0.1194976328303909 (R-squared: 0.0089602911500612)
Insider 90-day net shares: 20000 (net value USD: 127658.00)
ROIC (%): -116.53310444567255 (pretax: -147.51025879199054)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC 26.263537906137184, revenue growth 1y 15.162454873646208, 6m momentum 53.15884476534296
Sector percentiles: P/E , 6m momentum 59.52722063037249
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10129222324128974
Base cash flow: -34278428.57142857
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 8035.HK (Industrials — Integrated Freight & Logistics, Hong Kong)
Report date: 2025-12-31 (annual)
Stock price: 0.006377551020408163
Market cap: 31200000 (USD: 4010282.7763496144)
P/B ratio: 1.6339869281045751
Debt to equity: 0.9948
Current ratio: 1.21
Interest coverage ratio: -7.355591572123177
Buffett classification: The Gruesome
Rule of 40 score: -6.2681504651827336
Altman Z-score: 1.2547138782589529 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 80.14007022701291
Total shareholder yield (%): 80.14007022701291 (High Return)
Momentum (%): 1m 0, 3m -0.1275510204081672, 6m -17.09183673469387, 12m -37.4202806122449, composite -18.213222789115648 (Strong Downtrend)
Lynch category:  (confidence: Low)
Screener: long score 4, short score 5, recommendation: Neutral
Revenue growth 1y (%): -15.899587779257917
Revenue CAGR 3y (%): -25.531856895178485
Net income CAGR 3y (%): nan
FCF CAGR 3y (%): -15.963636059207564
Revenue deceleration: yes
Revenue growth consistency score: 22.53649406585465
Accrual ratio: -0.4204757106350212
FCF conversion rate: -0.8161670407181789
Beneish M-score: -5.993354583014115 (Likely Safe)
ROE (%): -81.3570545637909
Net margin (%): -11.800816295644688
Asset turnover: 1.961882862585802
Equity multiplier (leverage): 3.5140674548243656
ROE archetype: Low Return
FCF z-score: 4.441828084002451
Treasury beta 1y: 0.1778382187164171 (R-squared: 0.003082397906204878)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -59.91337187928212 (pretax: -75.8397112395976)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 47.4025974025974, ROIC 86.36363636363636, revenue growth 1y 54.54545454545454, 6m momentum 70.12987012987013
Sector percentiles: P/E , 6m momentum 66.12903225806451
Industry median P/E: 1.6524312026398307; industry median ROIC: 5.860649403527186
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.08569262681992337
Base cash flow: 80848.32904884359
DCF price per share: base 0, conservative 0, aggressive 1.9051822398010217e-06
Financial scorecard for 8118.HK (Consumer Cyclical — Furnishings, Fixtures & Appliances, Hong Kong)
Report date: 2025-10-31 (quarterly)
Stock price: 0.012755102040816327
Market cap: 50000000 (USD: 6435006.435006435)
P/B ratio: 2.9824038174768863
Debt to equity: 0.9319
Current ratio: 1.82
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 1.5482087628866001
Total shareholder yield (%): 1.5482087628866001 (Low Return)
Momentum (%): 1m -23.07692307692308, 3m -28.662536443148696, 6m -17.09183673469387, 12m 0.12755102040816046, composite -5.196185617103985 (Strong Uptrend)
Lynch category:  (confidence: Low)
Screener: long score 1, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.471658716365071 (Likely Safe)
Equity multiplier (leverage): 3.163524935169626
ROE archetype: Standard Business
FCF z-score: 2.3557181502625184
Treasury beta 1y: -0.03022015340989922 (R-squared: 8.952413122239004e-05)
Insider 90-day net shares: -110000000 (net value USD: -2629000.00)
ROIC (%): -134.80823268424945 (pretax: -170.64333251170817)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 65.03067484662577, ROIC 88.34355828220859, revenue growth 1y , 6m momentum 65.6441717791411
Sector percentiles: P/E , 6m momentum 62.03059805285118
Industry median P/E: 0.5336405520626155; industry median ROIC: 5.666341450255377
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.05
Base cash flow: -5693556.701030929
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 8545.HK (Consumer Cyclical — Leisure, Hong Kong)
Report date: 2025-09-30 (quarterly)
Stock price: 0.005102040816326531
Market cap: 45307692 (USD: 5823610.796915167)
P/B ratio: 0.24376463810190696
Debt to equity: 0.0325
Current ratio: 4.3
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 10.216808218789868
Total shareholder yield (%): 10.216808218789868 (High Return)
Momentum (%): 1m 0, 3m 33.16326530612247, 6m -0.510204081632644, 12m 0.12755102040816044, composite 10.92687074829933 (Flat)
Lynch category: Asset Play (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.6371598601718733 (Likely Safe)
Equity multiplier (leverage): 1.227055554701157
ROE archetype: Standard Business
FCF z-score: 3.734045545739606
Treasury beta 1y: -0.02408844708467672 (R-squared: 7.721797010944281e-05)
Insider 90-day net shares: 23840000 (net value USD: 122384.00)
ROIC (%): -4.356593452364424 (pretax: -5.514675256157499)
Incremental ROIC 3y (%): -6.855371154504597 (pretax: -8.563383944763935)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 7.092198581560284, ROIC 68.08510638297872, revenue growth 1y , 6m momentum 34.751773049645394
Sector percentiles: P/E , 6m momentum 33.27538247566064
Industry median P/E: 1.0205229016661044; industry median ROIC: 5.789930606709577
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.05164156497880716
Base cash flow: 662339.3316195374
DCF price per share: base 0.004326774974662365, conservative 0.0038092208428005306, aggressive 0.005095200005233397
Financial scorecard for 8CO.AX (Technology — Software - Application, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.02777777777777778
Market cap: 8739701 (USD: 5712222.875816993)
Debt to equity: -1.11072769790232
Current ratio: 0.28
Interest coverage ratio: -19.233074707424034
Buffett classification: The Gruesome
Rule of 40 score: -10.143535023000872
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 101.38888888888889, 3m 94.44444444444444, 6m 35.185185185185205, 12m 109.72222222222223, composite 44.58918688803747 (Flat)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 5, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: -0.3428466802664135
FCF conversion rate: -0.17716318238268094
Beneish M-score: -2.709056107894578 (Likely Safe)
ROE archetype: Standard Business
FCF z-score: 3.5219572935169583
Treasury beta 1y: 0.0018648587190110417 (R-squared: 1.696069605193815e-05)
Insider 90-day net shares: 3116028 (net value USD: 67407.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 6.60377358490566
Sector percentiles: P/E , 6m momentum 13.246579913246581
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.058756527147007756
Base cash flow: -37534.64052287582
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 9955.HK (Healthcare — Medical Distribution, China)
Report date: 2025-12-31 (annual)
Stock price: 0.06760204081632654
Market cap: 342230976 (USD: 48890139.428571425)
P/B ratio: 1.1799471600819313
Debt to equity: 1.2823
Current ratio: 1.03
Interest coverage ratio: -20.726436445937065
Return on net tangible assets (%): -282.29817158931087
Buffett classification: The Gruesome
Analyst consensus upside (%): 1314.5454545454545
Rule of 40 score: -61.57315542994728
Altman Z-score: -8.838116285789608 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 18.385988515897964
Total shareholder yield (%): 18.385988515897964 (High Return)
Momentum (%): 1m -1.8518518518518539, 3m -23.28637976929901, 6m -47.27040816326531, 12m -66.19897959183673, composite -45.37267080745341 (Strong Downtrend)
Lynch category: Asset Play (confidence: Low)
Screener: long score 0, short score 2, recommendation: Neutral
Revenue growth 1y (%): -51.470868371912324
Revenue CAGR 3y (%): -18.561559397974836
Revenue deceleration: yes
Revenue growth consistency score: 36.434548313658446
Beneish M-score: -2.49714830639567 (Likely Safe)
ROE (%): -99.30372090015983
Net margin (%): -56.934702746527336
Asset turnover: 0.7359140888107952
Equity multiplier (leverage): 2.3700709479750057
ROE archetype: Low Return
Treasury beta 1y: -0.10012475305172375 (R-squared: 0.0036906648466486385)
Insider 90-day net shares: 117700 (net value USD: 15842.00)
ROIC (%): -61.35525754243131 (pretax: -77.6648829651029)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 33.87096774193548, ROIC 69.35483870967742, revenue growth 1y 45.16129032258064, 6m momentum 69.35483870967742
Sector percentiles: P/E , 6m momentum 69.01862464183381
Industry median P/E: 0.9833576287657921; industry median ROIC: 6.89479587953176
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.06061397053247639
Base cash flow: -143367142.85714287
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for AARD (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 6.32
Market cap: 138307888 (USD: 138307888)
P/B ratio: 0.9484661400685167
Debt to equity: 0.0039000000000000003
Current ratio: 8.06
Return on net tangible assets (%): -24.805141057181615
Buffett classification: The Gruesome
Analyst consensus upside (%): 284.61538461538464
Rule of 40 score: 0
Altman Z-score: 5.444641116012928 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.07591757890193508
Total shareholder yield (%): 0.07591757890193508 (Low Return)
Momentum (%): 1m 27.419354838709687, 3m 17.25417439703155, 6m -57.89473684210527, 12m -53.08092056421678, composite -34.6059979246509 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.025202645397203516
FCF conversion rate: 0.8740503983694645
Beneish M-score: -2.7291504527061576 (Likely Safe)
ROE (%): -22.299464412066996
Asset turnover: 0
Equity multiplier (leverage): 1.1144102593237233
ROE archetype: Low Return
Treasury beta 1y: -0.0023925163995458455 (R-squared: 7.098276278152037e-05)
Insider 90-day net shares: 40000 (net value USD: 401873.00)
Incremental ROIC 3y (%): -100.36579031191042 (pretax: -127.04530419229168)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 10.740072202166065, ROIC , revenue growth 1y , 6m momentum 69.58483754512635
Sector percentiles: P/E , 6m momentum 73.28080229226362
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10182483630061022
Base cash flow: -57650000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for AAV.TO (Energy — Oil & Gas E&P, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 7.872340425531915
Market cap: 1862254464 (USD: 1339751412.9496403)
P/E ratio: 12.429441062534588
P/B ratio: 1.0945928491320536
Debt to equity: 0.5362
Current ratio: 0.38
Interest coverage ratio: 3.1822325011903954
Return on net tangible assets (%): -5.3984841518291
Buffett classification: The Gruesome
Analyst consensus upside (%): 71.80053428317008
Rule of 40 score: -20.60240621052375
Altman Z-score: 0.5254183848335653 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Magic formula: return on capital % 1.7631688344776357, earnings yield % 1.2249767795305833, rank 1842
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -1.7477528699008285
Total shareholder yield (%): -1.7477528699008285 (Minimal or Negative)
Momentum (%): 1m 12.348978937239385, 3m 13.527435610302357, 6m -2.479086290538232, 12m -2.845889485268548, composite -0.825452027142345 (Moderate Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 3, short score 6, recommendation: Neutral
Revenue growth 1y (%): 28.93953283992392
Net income growth 1y (%): 77.3364075814655
Revenue deceleration: no
Accrual ratio: 0.029414042729547955
FCF conversion rate: -2.1617109184502845
Beneish M-score: -2.615467330124675 (Likely Safe)
ROE (%): 1.7195949123066365
Net margin (%): 14.270111442959182
Asset turnover: 0.0651936347827582
Equity multiplier (leverage): 1.8483899202641183
ROE archetype: Low Return
P/E z-score: 5.035104656618291
Treasury beta 1y: -0.0022563727255059513 (R-squared: 0.0010345734438932334)
Insider 90-day net shares: 228696 (net value USD: 1642986.00)
ROIC (%): 2.701066035654535 (pretax: 4.009866571694897)
Incremental ROIC 3y (%): -47.14173550091585 (pretax: -60.24464746977441)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 18.243243243243242, P/B 25.225225225225223, ROIC 33.33333333333333, revenue growth 1y 11.486486486486488, 6m momentum 55.18018018018018
Sector percentiles: P/E 24.4796828543112, 6m momentum 53.815659068384534
Industry median P/E: 11.260253542132737; industry median ROIC: 0.8337488598897688
Sector median P/E: 11.598358576086895; sector median ROIC: 4.629877910100043
WACC: 0.06674548776309006
Base cash flow: -80072262.77372262
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for AAVAS.NS (Financial Services — Mortgage Finance, India)
Report date: 2026-06-30 (quarterly)
Stock price: 14.234104046242775
Market cap: 109340942336 (USD: 1153507145.6482751)
P/E ratio: 0.1870570885614578
Debt to equity: 3.1055
Buffett classification: The Great
Analyst consensus upside (%): 10484.71712256707
Rule of 40 score: 1.9321849078886102
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -8.619855448442767, 3m -5.082439467731337, 6m -11.911147923353251, 12m -34.24793682659454, composite -15.013052088647525 (Strong Downtrend)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 0, short score 4, recommendation: Neutral
Revenue growth 1y (%): 1.1630871639153328
Net income growth 1y (%): 10.900477616618364
Revenue deceleration: no
Revenue growth consistency score: 0.5522760280750049
Beneish M-score: -2.5716037180854197 (Likely Safe)
Net margin (%): 26.675707672617975
ROE archetype: Standard Business
P/E z-score: 4.158938332562211
Treasury beta 1y: 0.0003385281830528801 (R-squared: 2.1543541064688015e-05)
Insider 90-day net shares: -3468 (net value USD: -39682.00)
ROIC (%): 2.400679876577233 (pretax: 3.0809087938263904)
Incremental ROIC 3y (%): 3.122410442822674 (pretax: 4.041999126873119)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 14.130434782608695, P/B , ROIC 14.130434782608695, revenue growth 1y 29.347826086956523, 6m momentum 31.521739130434785
Sector percentiles: P/E 9.467149508535954, 6m momentum 55.3543714433523
Industry median P/E: 1.1112600720512609; industry median ROIC: 2.400679876577233
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.07567723039827301
Base cash flow: 70640515.04874946
DCF price per share: base 0.255500606506181, conservative 0.05983960967632691, aggressive 0.6118621727677619
Financial scorecard for ACIU (Healthcare — Biotechnology, Switzerland)
Report date: 2026-03-31 (quarterly)
Stock price: 2.23
Market cap: 226955072 (USD: 226955072)
P/B ratio: 7.100331724487855
Debt to equity: 0.1365
Current ratio: 0.87
Interest coverage ratio: -227.5076923076923
Buffett classification: The Gruesome
Analyst consensus upside (%): 209.45454545454544
Rule of 40 score: 226.926775147929
Altman Z-score: -4.038203940391378 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.16219124894586404
Total shareholder yield (%): 0.16219124894586404 (Low Return)
Momentum (%): 1m -12.20472440944882, 3m -21.478873239436616, 6m -39.72972972972973, 12m -8.230452674897126, composite -18.893951332657647 (Flat)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 7, recommendation: Neutral
Revenue growth 1y (%): 24.33333333333334
Revenue deceleration: no
Beneish M-score: -1.0406744185595271 (Strong Manipulation Signal)
ROE (%): -38.45107109514682
Net margin (%): -1322.698838248436
Asset turnover: 0.007621978623437087
Equity multiplier (leverage): 3.813991699312683
ROE archetype: Low Return
Treasury beta 1y: -0.005503732693796762 (R-squared: 0.0009471727536345192)
Insider 90-day net shares: -40000 (net value USD: -118720.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 53.88086642599278, ROIC , revenue growth 1y 12.093862815884476, 6m momentum 60.46931407942239
Sector percentiles: P/E , 6m momentum 65.43696275071633
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.13102336362377717
Base cash flow: -87125316.4556962
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for AIDX.TO (Healthcare — Medical Care Facilities, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.4680851063829788
Market cap: 215397056 (USD: 154961910.7913669)
P/B ratio: 1.8977605533512238
Debt to equity: 0.7140000000000001
Current ratio: 0.89
Interest coverage ratio: -2.006908462867012
Buffett classification: The Gruesome
Analyst consensus upside (%): 327.6923076923076
Rule of 40 score: 6.447399903754442
Altman Z-score: 0.04383161130368142 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.30424884994408696
Total shareholder yield (%): 0.30424884994408696 (Low Return)
Momentum (%): 1m -14.78450627386797, 3m -32.497200447928314, 6m -28.22695035460993, 12m -54.85136562547155, composite -35.914143564885634 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 3, short score 5, recommendation: Neutral
Revenue growth 1y (%): 327.8882405097965
Revenue deceleration: no
Accrual ratio: -0.03678235236101827
FCF conversion rate: -0.5243172192200964
Beneish M-score: -2.857321991810805 (Likely Safe)
ROE (%): -5.53894040932485
Net margin (%): -20.61914656548318
Asset turnover: 0.11702899059618029
Equity multiplier (leverage): 2.2954220435112327
ROE archetype: Low Return
Treasury beta 1y: 0.0011971257259576211 (R-squared: 7.804900696329128e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -12.184383455740242 (pretax: -15.423270197139546)
Incremental ROIC 3y (%): -5.887045777257812 (pretax: -7.4519566800731765)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 37.142857142857146, ROIC 71.42857142857143, revenue growth 1y 0.4761904761904762, 6m momentum 70.47619047619048
Sector percentiles: P/E , 6m momentum 56.80515759312321
Industry median P/E: 1.7425206697700268; industry median ROIC: 5.681103510179656
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: -22556204.37956204
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for AIH.AX (Industrials — Specialty Industrial Machinery, United Kingdom)
Report date: 2024-09-30 (annual)
Stock price: 0.4375
Market cap: 266061984 (USD: 354749312)
Debt to equity: 0.7282
Current ratio: 1.76
Interest coverage ratio: 4.2371152154793315
Buffett classification: The Good
Rule of 40 score: 44.490425309029945
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0.05600198786760907
Buyback yield (%): 0
Total shareholder yield (%): 0.05600198786760907 (Low Return)
Momentum (%): 1m -9.374999999999993, 3m -30.39772727272728, 6m -33.463541666666664, 12m , composite -31.930634469696972 (Strong Downtrend)
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 1, short score 2, recommendation: Neutral
Revenue growth 1y (%): 44.49042530902996
Net income growth 1y (%): -52.86334725828912
Revenue deceleration: yes
Revenue growth consistency score: 31.561846368904128
Beneish M-score: -2.0821145501738116 (Likely Safe)
ROE archetype: Standard Business
P/E z-score: 1.6135871730193891
Treasury beta 1y: -0.008505268408128801 (R-squared: 0.005564199302867498)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y 3.6608863198458574, 6m momentum 81.31021194605009
Sector percentiles: P/E , 6m momentum 77.7521761392729
Industry median P/E: 0.34832165205981025; industry median ROIC: 8.620128805291433
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.1019
Base cash flow: 14601333.33333333
DCF price per share: base 1.1471148421050126, conservative 0.6623887829833097, aggressive 2.0024710891305824
Financial scorecard for AMBALALSA.NS (Healthcare — Drug Manufacturers - Specialty & Generic, India)
Report date: 2026-03-31 (annual)
Stock price: 0.33433113129644926
Market cap: 2482152448 (USD: 26305134.039847393)
Debt to equity: 0.35700000000000004
Current ratio: 1.27
Interest coverage ratio: 4.017252443479119
Return on net tangible assets (%): 13.291504044196452
Buffett classification: The Good
Rule of 40 score: -3.055788004377553
Altman Z-score: 1.6911600843655408 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 1.764109615593357, 3m -10.740701372173506, 6m , 12m , composite -10.740701372173506 ()
Lynch category: Turnaround (confidence: Low)
Screener: long score 2, short score 4, recommendation: Neutral
Revenue growth 1y (%): -8.404897226573937
Revenue deceleration: no
Accrual ratio: 0.03603722254997479
FCF conversion rate: 0.41216614710590616
Beneish M-score: -2.413788196075263 (Likely Safe)
ROE (%): 11.38421985935009
Net margin (%): 8.857696247712004
Asset turnover: 0.6921112928446245
Equity multiplier (leverage): 1.856977133250216
ROE archetype: Standard Business
P/E z-score: 3.5487516479233854
FCF z-score: 3.548751647923383
Treasury beta 1y: 0.11392671059116562 (R-squared: 0.024392469106603396)
Insider 90-day net shares: 372642 (net value USD: 107672.00)
ROIC (%): 7.897357799801105 (pretax: 8.209291722063403)
Incremental ROIC 3y (%): 38.43595920631358 (pretax: 32.90246544901234)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B , ROIC 37.5366568914956, revenue growth 1y 57.18475073313783, 6m momentum 
Industry median P/E: 0.8814835040505258; industry median ROIC: 5.747543732928968
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: 1859749.8940228913
DCF price per share: base 0.897063385931455, conservative 0.7015892451852459, aggressive 1.1946276117068275
Financial scorecard for AMCX (Communication Services — Entertainment, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 9.79
Market cap: 430052288 (USD: 430052288)
P/E ratio: 7.629213483146067
P/B ratio: 0.22291305204339462
Debt to equity: 1.8637000000000001
Current ratio: 1.76
Interest coverage ratio: 0.8610230983190229
Buffett classification: The Great
Analyst consensus upside (%): 10.456553755522826
Rule of 40 score: 1.9750000229099811
Altman Z-score: 1.2179176951897728 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 4.7282193636647385, earnings yield % 2.0311165016885124, rank 860
Dividend yield (%): 0
Buyback yield (%): 1.5342320420348514
Debt paydown yield (%): 2.424821420785
Total shareholder yield (%): 3.9590534628198513 (Low Return)
Momentum (%): 1m 0.41025641025640147, 3m 15.584415584415565, 6m 23.144654088050302, 12m 50.615384615384606, composite 29.576356557488623 (Strong Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 3, recommendation: Neutral
Revenue growth 1y (%): -2.36045047754726
Net income growth 1y (%): -177.47934816954816
Revenue deceleration: no
Accrual ratio: -0.020991807129081858
FCF conversion rate: -3.7762176648799812
Beneish M-score: -2.5519738854306766 (Likely Safe)
ROE (%): -1.7147007315750091
Net margin (%): -3.1660478079859513
Asset turnover: 0.13881878802458872
Equity multiplier (leverage): 3.901419193579163
ROE archetype: Low Return
P/E z-score: 3.7040004098499835
FCF z-score: 4.411270119321343
Treasury beta 1y: 0.0006586066218978146 (R-squared: 3.757548572027388e-05)
Insider 90-day net shares: -5963 (net value USD: -47483.00)
ROIC (%): 7.49584917209852 (pretax: 10.900549127188587)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 27.830188679245282, P/B 7.0754716981132075, ROIC 21.22641509433962, revenue growth 1y 38.67924528301887, 6m momentum 15.09433962264151
Sector percentiles: P/E 34.25549227013832, 6m momentum 10.577705451586656
Industry median P/E: 3.7313797891504157; industry median ROIC: 1.542068936425999
Sector median P/E: 1.436628982900151; sector median ROIC: 4.830798676039866
WACC: 0.07192246544376373
Base cash flow: 1009694000
DCF price per share: base 611.4427737965276, conservative 523.2409235971301, aggressive 723.0311435396297
Financial scorecard for ANGO (Healthcare — Medical Instruments & Supplies, United States)
Report date: 2026-05-31 (annual)
Stock price: 13.59
Market cap: 561707136 (USD: 561707136)
P/B ratio: 2.7776720369969268
Debt to equity: 0.0641
Current ratio: 2.19
Return on net tangible assets (%): -15.796788140827672
Buffett classification: The Gruesome
Analyst consensus upside (%): 74.21602787456445
Rule of 40 score: 5.260479585780594
Altman Z-score: 2.377636291975051 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 4.942084942084947, 3m 22.432432432432435, 6m 30.924855491329467, 12m 49.17672886937432, composite 31.83625660393234 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 8, recommendation: Short
Revenue growth 1y (%): 8.045360413183955
Revenue deceleration: no
Revenue growth consistency score: 0.614774261844717
Accrual ratio: -0.10777487917763114
FCF conversion rate: -1.4939938623410784
Beneish M-score: -2.8678186240373713 (Likely Safe)
ROE (%): -6.627307645373668
Net margin (%): -13.168681515350952
Asset turnover: 0.3281556377772852
Equity multiplier (leverage): 1.5336101248757925
ROE archetype: Low Return
FCF z-score: 0.9823374294886571
Treasury beta 1y: 0.0031846022073959476 (R-squared: 0.0010233178476108105)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -15.081873444994484 (pretax: -19.090979044296816)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 46.62576687116564, ROIC 69.32515337423312, revenue growth 1y 32.515337423312886, 6m momentum 7.975460122699387
Sector percentiles: P/E , 6m momentum 10.386819484240688
Industry median P/E: 15.690276110444179; industry median ROIC: 5.717819487534456
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.0656
Base cash flow: -16368000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for ANGX (Communication Services — Entertainment, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 4.05
Market cap: 755342080 (USD: 755342080)
Debt to equity: -2.5399628714784748
Current ratio: 0.59
Interest coverage ratio: -0.4419598551804037
Buffett classification: The Gruesome
Analyst consensus upside (%): 162.29508196721315
Rule of 40 score: -3.7169979990281226
Altman Z-score: 0.17067133593618633 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0.11880921555436182
Total shareholder yield (%): 0.11880921555436182 (Low Return)
Momentum (%): 1m 28.164556962025305, 3m 60.71428571428571, 6m -6.25000000000001, 12m , composite 27.23214285714285 (Moderate Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): 270.94002022065865
Revenue deceleration: no
Accrual ratio: -0.06077170838561539
FCF conversion rate: 0.058628214366094465
Beneish M-score: -2.579998909685909 (Likely Safe)
Net margin (%): -11.950869304049572
Asset turnover: 0.5401828235175977
ROE archetype: Standard Business
Treasury beta 1y: 0.05070741429323637 (R-squared: 0.039977286936654415)
Insider 90-day net shares: 321544 (net value USD: 982574.00)
ROIC (%): -423.0449571563439 (pretax: -535.499945767524)
Incremental ROIC 3y (%): -794.8563295224735 (pretax: -1006.147252560093)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B , ROIC 77.35849056603774, revenue growth 1y 0.9433962264150944, 6m momentum 40.56603773584906
Sector percentiles: P/E , 6m momentum 36.45240032546786
Industry median P/E: 3.7313797891504157; industry median ROIC: 1.542068936425999
Sector median P/E: 1.436628982900151; sector median ROIC: 4.830798676039866
WACC: 0.0539294824265105
Base cash flow: -155643151
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for APTA.L (Healthcare — Biotechnology, United Kingdom)
Report date: 2025-12-31 (quarterly)
Stock price: 0
Market cap: 16411933 (USD: 22178287.837837838)
P/B ratio: 0.15335747669773633
Debt to equity: 0.1478
Current ratio: 2.04
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 1.0036966845846875
Total shareholder yield (%): 1.0036966845846875 (Low Return)
Momentum (%): 1m -100, 3m -100, 6m -100, 12m , composite -100 (Strong Downtrend)
Lynch category: Asset Play (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.491670258017313 (Likely Safe)
Equity multiplier (leverage): 1.8073195694635538
ROE archetype: Standard Business
Treasury beta 1y: 0.003303703069437462 (R-squared: 5.2331058626548865e-05)
Insider 90-day net shares: 5000000 (net value USD: 70000.00)
ROIC (%): -256.70147420147424 (pretax: -324.9385749385749)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 1.6245487364620936, ROIC 33.03249097472924, revenue growth 1y , 6m momentum 79.78339350180505
Sector percentiles: P/E , 6m momentum 80.90974212034384
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.09010183299389002
Base cash flow: -3020547.9452054794
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for AR3.AX (Basic Materials — Other Industrial Metals & Mining, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.0625
Market cap: 24327082 (USD: 15900053.594771242)
Debt to equity: 0.0203
Current ratio: 1.82
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -9.374999999999998, 3m -37.500000000000014, 6m -60.32608695652174, 12m -27.40384615384615, composite -39.239995386921926 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: 0.01748903406790618 (R-squared: 0.0033715064112865636)
Insider 90-day net shares: -190000 (net value USD: -17936.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 73.52206494587843
Sector percentiles: P/E , 6m momentum 78.317601332593
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.06285
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0